AJ_ wrote:
I thought we are trying to block the "first drink effect", which would make a fast acting short-lived version interesting. Additionally, there is a study using actual Naltrexone in a nasal form going on, but I am not sure of the results or details yet. I wrote the doctor conducting the trials but have not heard back.
Quote:
We're trying to block all the endorphins released by drinking, not just the initial ones from the first drink. The first drink effect is one of the things we enjoy about drinking, but blocking it doesn't make you stop craving. You need to unwire the neural pathways formed over years of drinking, and that requires blocking all endorphins, not just the initial ones. And if we blocked the "first drink effect", we'd probably then have to coin a "second or third drink effect" and worry about that. 25mg NAL would block the first drink effect, but as we've seen with a few people on the board, 25 mg isn't always enough.
I'm not so sure this is correct. Studies with mice have shown that endorphin release is stimulated with low doses of alcohol, but not with high doses. If I understand this correctly, there would be a sweet spot for attacking the problem with Naltrexone. This would seem to be during the low-dose phase of drinking, presumably the first drink or two.